TOP STORIES
Endo just announced this morning it will acquire Par Pharmaceutical for $8.05 billion – a shakeup in the generics industry.
MIT does a nice job outlining what it’s doing in single-cell genomics, “to study individual cells at a speed and scale previously unthinkable.”

Using Data to Help Healthcare Practices Succeed
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
LIFE SCIENCE
Veracyte’s Percepta Bronchial Genomic Classifier diagnostic delivered strong news about its ability to help people avoid invasive lung biopsies.
Boehringer Ingelheim exercised its option to buy Pharmaxis’ Phase 1 anti-inflammatory drug to treat steatohepatitis and COPD
Abcodia raised $8.25 million through by Cambridge Innovation Capital and Scottish Equity Partners to develop cancer-detection tests.

Tips for Greater Healthcare Practice Success in 2025
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Astellas Pharma reported good news from its Phase 3b BESIDE clinical trial.
PAYERS-PROVIDERS
The American Journal of Managed Care is getting louder on healthcare reform: a new online contributor forum will focus on issues that matter to payers.
What do you know? Medical residents make people happy – even surgeons.
Partners Healthcare: Innovative but still struggling financially.
TECH
Healthcare had the fourth-largest early-stage tech deal in April: Honor Technology ($20 million).
Agree? “There are just too many damn apps.”
A LITTLE EXTRA
Here it is: the trailer for the new Steve Jobs movie.
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.
Photo: Wikimedia Commons